Skip to main content
. 2018 May 17;7(11):e008951. doi: 10.1161/JAHA.118.008951

Table 4.

Crude IRs and HRs With 95% CIs of First‐Ever IS and MI From Time‐Varying Cox Models Across Categories of TPA Before and After Adjustment for CRP: The Tromsø Study (1994–2013)

TPA na Events IR (95% CI)b Model 1 HR (95% CI)c Model 1 +CRP HR (95% CI)c Absolute Attenuation of HR After Inclusion of CRP in the Modeld Attenuation of HR After Inclusion of CRP in the Model, % Model 2 HR (95% CI)e
IS
No plaque 8945 177 3.1 (2.6–3.5) Reference Reference Reference
TPA below median 4362 177 6.2 (5.3–7.2) 1.37 (1.11–1.69) 1.36 (1.10–1.68) 0.01 1.7 1.33 (1.08–1.65)
TPA above median 4361 317 11.2 (10.1–12.6) 1.93 (1.31–1.77) 1.85 (1.53–2.24) 0.08 8.6 1.65 (1.36–2.01)
MI
No plaque 8881 300 5.2 (4.7–5.9) Reference Reference Reference
TPA below median 4285 291 10.4 (9.3–11.7) 1.47 (1.25–1.73) 1.46 (1.24–1.72) 0.01 2.1 1.31 (1.11–1.55)
TPA above median 4288 488 17.7 (16.2–19.4) 2.14 (1.84–2.49) 2.07 (1.78–2.41) 0.07 6.1 1.64 (1.41–1.92)

CI indicates confidence interval; CRP, C‐reactive protein; HR, hazard ratio; IR, incidence rate; IS, ischemic stroke; MI, myocardial infarction; TPA, total plaque area.

a

Observations.

b

Crude IRs per 1000 person‐years.

c

Age as time scale, adjusted for sex.

d

Change in HR from model 1 to model 1+CRP. CRP was log transformed.

e

Age as time scale, adjusted for sex, total cholesterol, high‐density lipoprotein cholesterol, diabetes mellitus, systolic blood pressure, smoking, body mass index, lipid‐lowering medication, antihypertensive medication, and CRP (log transformed).